Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
eBay
EBAY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -41.03%2M | -41.03%2M | -57.65%2.19M | 38.89%3.69M | -67.72%1.67M | -3.47%3.4M | -3.47%3.4M | -18.32%5.17M | -70.62%2.66M | -52.16%5.17M |
-Cash and cash equivalents | -41.03%2M | -41.03%2M | -57.65%2.19M | 38.89%3.69M | -67.72%1.67M | -3.47%3.4M | -3.47%3.4M | -18.32%5.17M | -70.62%2.66M | -52.16%5.17M |
Receivables | -60.34%69K | -60.34%69K | -93.13%9K | 23.08%16K | 29.82%74K | 62.62%174K | 62.62%174K | 37.89%131K | -85.87%13K | -51.28%57K |
-Accounts receivable | -60.34%69K | -60.34%69K | -93.13%9K | 23.08%16K | 29.82%74K | 62.62%174K | 62.62%174K | 37.89%131K | -85.87%13K | -51.28%57K |
Inventory | -57.80%319K | -57.80%319K | -21.23%731K | -22.47%766K | -17.92%774K | -12.40%756K | -12.40%756K | 21.94%928K | 18.61%988K | 110.96%943K |
Current deferred assets | ---- | ---- | ---- | ---- | 190.48%61K | ---- | ---- | --0 | --65K | --21K |
Other current assets | -23.85%249K | -23.85%249K | 3.08%234K | -31.64%188K | -14.97%250K | 39.15%327K | 39.15%327K | --227K | --275K | --294K |
Total current assets | -43.27%2.64M | -43.27%2.64M | -51.00%3.16M | 16.58%4.66M | -56.39%2.83M | -12.33%4.65M | -12.33%4.65M | -15.00%6.46M | -61.43%4M | -45.97%6.48M |
Non current assets | ||||||||||
Net PPE | -74.73%119K | -74.73%119K | -77.03%119K | -78.65%120K | -27.35%425K | -11.96%471K | -11.96%471K | -10.69%518K | -9.35%562K | -11.76%585K |
-Gross PPE | -68.70%159K | -68.70%159K | -69.31%159K | -71.71%159K | -20.85%463K | -9.93%508K | -9.93%508K | -10.69%518K | -9.35%562K | -11.76%585K |
-Accumulated depreciation | -8.11%-40K | -8.11%-40K | ---40K | ---39K | ---38K | -27.59%-37K | -27.59%-37K | ---- | ---- | ---- |
Non current deferred assets | --49K | --49K | --112K | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other non current assets | ---- | ---- | ---- | ---- | 0.00%34K | 0.00%34K | 0.00%34K | 0.00%34K | 0.00%34K | 3.03%34K |
Total non current assets | -66.73%168K | -66.73%168K | -58.15%231K | -79.87%120K | -25.85%459K | -11.25%505K | -11.25%505K | -10.10%552K | -8.87%596K | -11.06%619K |
Total assets | -45.57%2.81M | -45.57%2.81M | -51.56%3.39M | 4.07%4.78M | -53.72%3.29M | -12.22%5.16M | -12.22%5.16M | -14.63%7.01M | -58.32%4.6M | -44.06%7.1M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -85.68%125K | -85.68%125K | -47.81%333K | -46.33%446K | -48.17%567K | -34.01%873K | -34.01%873K | -60.17%638K | -56.61%831K | 75.04%1.09M |
-accounts payable | -82.47%125K | -82.47%125K | -47.81%333K | -46.33%446K | -50.00%547K | -46.11%713K | -46.11%713K | -60.17%638K | -56.61%831K | 75.04%1.09M |
-Total tax payable | --0 | --0 | --0 | --0 | --20K | --160K | --160K | ---- | ---- | ---- |
Current accrued expenses | -56.12%147K | -56.12%147K | 20.11%227K | 0.69%145K | -17.51%245K | -14.54%335K | -14.54%335K | -27.59%189K | -50.85%144K | -2.30%297K |
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | -1.10%180K | 18.40%193K | 18.40%193K | 8.13%173K | 8.82%185K | 8.33%182K |
-Current capital lease obligation | --0 | --0 | --0 | --0 | -1.10%180K | 18.40%193K | 18.40%193K | 8.13%173K | 8.82%185K | 8.33%182K |
Current liabilities | -80.59%272K | -80.59%272K | -44.00%560K | -49.05%591K | -36.94%992K | -25.40%1.4M | -25.40%1.4M | -50.57%1M | -51.22%1.16M | 43.39%1.57M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | --0 | --0 | --0 | --0 | -56.35%141K | -52.04%176K | -52.04%176K | -41.40%242K | -40.35%275K | -35.91%323K |
-Long term capital lease obligation | --0 | --0 | --0 | --0 | -56.35%141K | -52.04%176K | -52.04%176K | -41.40%242K | -40.35%275K | -35.91%323K |
Total non current liabilities | --0 | --0 | --0 | --0 | -56.35%141K | -52.04%176K | -52.04%176K | -41.40%242K | -40.35%275K | -35.91%323K |
Total liabilities | -82.75%272K | -82.75%272K | -54.91%560K | -58.82%591K | -40.24%1.13M | -29.76%1.58M | -29.76%1.58M | -49.01%1.24M | -49.45%1.44M | 18.43%1.9M |
Shareholders'equity | ||||||||||
Share capital | --1K | --1K | --1K | -66.67%1K | --0 | --0 | --0 | --0 | 200.00%3K | 200.00%3K |
-common stock | --1K | --1K | --1K | -66.67%1K | --0 | --0 | --0 | --0 | 200.00%3K | 200.00%3K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -14.93%-43.54M | -14.93%-43.54M | -18.01%-42.06M | -19.92%-40.63M | -23.96%-39.37M | -27.81%-37.89M | -27.81%-37.89M | -30.14%-35.64M | -36.60%-33.88M | -45.77%-31.76M |
Paid-in capital | 11.12%46.08M | 11.12%46.08M | 8.43%44.9M | 21.01%44.82M | 12.34%41.52M | 24.63%41.47M | 24.63%41.47M | 24.88%41.41M | 12.28%37.04M | 12.42%36.96M |
Total stockholders'equity | -29.19%2.54M | -29.19%2.54M | -50.84%2.83M | 32.62%4.19M | -58.64%2.15M | -1.38%3.58M | -1.38%3.58M | -0.12%5.77M | -61.39%3.16M | -53.08%5.21M |
Total equity | -29.19%2.54M | -29.19%2.54M | -50.84%2.83M | 32.62%4.19M | -58.64%2.15M | -1.38%3.58M | -1.38%3.58M | -0.12%5.77M | -61.39%3.16M | -53.08%5.21M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |